Common Blood Pressure Medications
The five major classes of antihypertensive medications suitable for initiating and maintaining treatment are: thiazide diuretics, calcium channel blockers, ACE inhibitors, angiotensin receptor blockers (ARBs), and beta-blockers. 1
First-Line Medication Classes
Thiazide and Thiazide-Like Diuretics
- Hydrochlorothiazide is the most commonly prescribed thiazide diuretic 2
- Chlorthalidone provides superior 24-hour blood pressure reduction compared to hydrochlorothiazide and should be preferentially used, particularly in resistant hypertension 1
- Indapamide is another thiazide-like diuretic effective for blood pressure control 1
- These agents have been the basis of antihypertensive therapy in the majority of placebo-controlled outcome trials demonstrating reduction in cardiovascular events 1
ACE Inhibitors
- Enalapril is a commonly used ACE inhibitor 2
- Lisinopril is frequently prescribed in combination therapy 3
- Ramipril has demonstrated cardiovascular event reduction in high-risk patients 4
- ACE inhibitors are contraindicated in pregnancy, bilateral renal artery stenosis, and history of angioedema 3
Angiotensin Receptor Blockers (ARBs)
- Candesartan is a first-line ARB option 2
- Valsartan is commonly used in combination therapy 5
- Losartan demonstrated superior stroke reduction compared to beta-blockers in the LIFE study 1
- ARBs should never be combined with ACE inhibitors due to lack of benefit and increased adverse events 3, 5
Calcium Channel Blockers
- Amlodipine is the most commonly prescribed dihydropyridine calcium channel blocker 2
- Nicardipine is particularly effective in hypertensive emergencies and may be superior to labetalol for achieving short-term blood pressure targets 1
- Clevidipine is used for acute blood pressure management in specific conditions 1
Beta-Blockers
- Atenolol is indicated for hypertension, angina, and post-myocardial infarction management 6
- Metoprolol is effective for hypertension, angina, and myocardial infarction 7
- Labetalol is preferred in hypertensive emergencies, particularly with acute aortic dissection 1
- Esmolol is a short-acting beta-blocker used in acute settings 1
- Beta-blockers should not be used in patients with metabolic syndrome or high diabetes risk, especially when combined with thiazide diuretics, due to dysmetabolic effects 1
Combination Therapy Approach
More than 70% of adults treated for hypertension will require at least two antihypertensive agents to achieve adequate blood pressure control. 8
Preferred Two-Drug Combinations
- ACE inhibitor or ARB + dihydropyridine calcium channel blocker (e.g., lisinopril + amlodipine or valsartan + amlodipine) is the optimal initial combination for confirmed hypertension ≥140/90 mmHg 3, 5
- Thiazide diuretic + any other class consistently demonstrates superior efficacy compared to combinations without a diuretic 1
Three-Drug Combination
- RAS blocker (ACE inhibitor or ARB) + calcium channel blocker + thiazide/thiazide-like diuretic is the recommended triple therapy when two drugs fail to achieve target blood pressure 3, 5
Additional Agents for Resistant Hypertension
Aldosterone Antagonists
- Spironolactone and other mineralocorticoid receptor antagonists provide add-on benefit in patients uncontrolled on multidrug regimens 1
Loop Diuretics
- Furosemide requires at least twice-daily dosing due to short duration of action 1
- Torsemide has longer duration and can be dosed once daily 1
- Loop diuretics are necessary in patients with chronic kidney disease (creatinine clearance <30 mL/min) for effective volume control 1
Centrally Acting Agents
- These are effective but have higher incidence of adverse effects and lack outcome data 1
Direct Vasodilators
- Hydralazine is used in resistant hypertension and is preferred in eclampsia/preeclampsia 1
- Minoxidil is very effective at higher doses but requires concomitant beta-blocker and loop diuretic due to reflex tachycardia and fluid retention 1
Critical Prescribing Considerations
The main benefits of antihypertensive therapy are due to blood pressure lowering per se, largely independent of the specific drugs employed. 1 However, specific comorbidities and patient characteristics should guide drug selection 1.